年龄相关差异:凝血功能障碍对单纯性创伤性脑损伤患者结局的影响
该回顾性观察研究纳入2013至2018年日本两家三级急诊重症医学中心的1036例单纯性颅脑损伤患者(头AIS≥3且其他部位AIS<3),分为非老年组(16-64岁,n=501)和老年组(≥65岁,n=535)。以INR>1.2定义凝血功能障碍,采用单因素和多因素模型评估其对GOS-E评分、院内死亡率和无通气天数的影响,并用广义相加模型做基于年龄的评估。多因素模型显示,在非老年组中,年龄和TBI相关凝血功能障碍与较低的GOS-E评分、院内死亡率和较短的无通气天数显著相关;而在老年组中,凝血功能障碍对所有结局均未观察到显著影响。随着年龄超过65岁,凝血功能障碍与GOS-E评分之间的相关程度下降。
要点
- 非老年组(16-64岁)中,TBI相关凝血功能障碍(INR>1.2)与较低的GOS-E评分、院内死亡率和较短的无通气天数显著相关。
- 老年组(≥65岁)中,凝血功能障碍对所有结局(GOS-E评分、院内死亡率、无通气天数)均未观察到显著影响。
- 随着年龄超过65岁,凝血功能障碍与GOS-E评分之间的相关程度下降。
- 研究结论:老年单纯性TBI患者中,凝血功能障碍对功能和生存结局的影响较小。
适用人群与场景
- 单纯性创伤性脑损伤患者,纳入标准为头Abbreviated Injury Scale≥3且其他部位Abbreviated Injury Scale<3。
- 研究分为非老年组(16-64岁,n=501)和老年组(≥65岁,n=535)。
- 场景为日本两家三级急诊重症医学中心,2013至2018年。
诊断标准与关键阈值
- 凝血功能障碍定义为国际标准化比值(INR)>1.2。
研究设计与关键结果
- 研究类型为回顾性观察性队列研究,纳入1036例单纯性TBI患者(非老年组n=501,老年组n=535)。
- 多因素模型显示,非老年组中年龄和TBI相关凝血功能障碍与较低的GOS-E评分、院内死亡率和较短的无通气天数显著相关;老年组中凝血功能障碍对所有结局均未观察到显著影响。
- 广义相加模型显示,年龄超过65岁后,凝血功能障碍与GOS-E评分之间的相关程度下降。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究;证据等级:Therapeutic study, Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,老年单纯性TBI患者中凝血功能障碍对功能和生存结局的影响较小。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although age and coagulopathy are well-known predictors of poor outcome after traumatic brain injury (TBI), the interaction effect of these two predictors remains unclear.
OBJECTIVES: We assessed age-related differences in the impact of coagulopathy on the outcome following isolated TBI.
METHODS: We conducted a retrospective observational study in two tertiary emergency critical care medical centers in Japan from 2013 to 2018. A total of 1036 patients with isolated TBI (head Abbreviated Injury Scale ≥ 3 and other Abbreviated Injury Scale < 3) were selected and divided into the nonelderly (n = 501, 16-64 years) and elderly group (n = 535, age ≥65 years). We further evaluated the impact of coagulopathy (international normalized ratio, >1.2) on the outcomes (Glasgow Outcome Scale-Extended [GOS-E] scores, in-hospital mortality, and ventilation-free days) in both groups using univariate and multivariate models. Further, we conducted an age-based assessment of the impact of TBI-associated coagulopathy on GOS-E using a generalized additive model.
RESULTS: The multivariate model showed a significant association of age and TBI-associated coagulopathy with lower GOS-E scores, in-hospital mortality, and shorter ventilation-free days in the nonelderly group; however, significant impact of coagulopathy was not observed for all the outcomes in the elderly group. There was a decrease in the correlation degree between coagulopathy and GOS-E scores decreased with those older than 65 years.
CONCLUSION: There was a low impact of coagulopathy on functional and survival outcomes in geriatric patients with isolated TBI.
LEVEL OF EVIDENCE: Therapeutic study, Level IV.
参考来源
- Takayama W, Endo A, Koguchi H, et al. Age-related differences in the impact of coagulopathy in patients with isolated traumatic brain injury: An observational cohort study. J Trauma Acute Care Surg. 2020. PMID: 32502089. doi:10.1097/TA.0000000000002796
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。